Organogenesis

(NASDAQ) ORGO

Current Price$2.67

Market Cap$342.28M

Since IPO (2019)-80%

5 Year-84%

1 Year-10%

1 Month+10%

Organogenesis Financials at a Glance

Market Cap

$342.28M

Revenue (TTM)

$513.57M

Net Income (TTM)

$284.00K

EPS (TTM)

$-0.16

P/E Ratio

-16.73

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Price

$2.67

Volume

19,065

Open

$2.65

Price

$2.67

Volume

19,065

Open

$2.65

Previous Close

$2.67

Daily Range

$2.61 - $2.69

52-Week Range

$2.04 - $7.08

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Price

$2.67

Volume

19,065

Open

$2.65

Previous Close

$2.67

Daily Range

$2.61 - $2.69

52-Week Range

$2.04 - $7.08

ORGO News

Page 1

ORGO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Organogenesis

Industry

Biotechnology

Sector

Health Care

Employees

854

CEO

Gary S. Gillheeney, Sr., MBA

Website

www.organogenesis.com

Headquarters

Canton, MA 02021, US

ORGO Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

Net Income Margin

-0%

Return on Equity

73%

Return on Capital

Return on Assets

-0%

Earnings Yield

-5.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$342.28M

Shares Outstanding

128.68M

Volume

19.07K

Avg. Volume

1.47M

Financials (TTM)

Gross Profit

$425.51M

Operating Income

$55.87M

EBITDA

$82.81M

Operating Cash Flow

$10.31M

Capital Expenditure

$14.15M

Free Cash Flow

$24.46M

Cash & ST Invst.

$93.68M

Total Debt

$132.84M

Organogenesis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$37.23M

-57.1%

Gross Profit

$914.00K

-101.5%

Gross Margin

-2.46%

N/A

Market Cap

$342.28M

N/A

Market Cap/Employee

$393.87K

N/A

Employees

869

N/A

Net Income

$56.16M

-198.0%

EBITDA

$52.66M

-279.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$21.24M

-68.5%

Accounts Receivable

$116.91M

+13.2%

Inventory

$28.43M

-3.1%

Long Term Debt

$61.14M

+83.2%

Short Term Debt

$9.72M

+5.0%

Return on Assets

-0.05%

N/A

Return on Invested Capital

2.48%

N/A

Free Cash Flow

$17.98M

+176.3%

Operating Cash Flow

$21.13M

+206.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SIGASIGA Technologies, Inc.

SIGASIGA Technologies, Inc.$4.68-0.64%

BCYCBicycle Therapeutics plc

BCYCBicycle Therapeutics plc$4.55+2.25%

SNDLSNDL Inc.

SNDLSNDL Inc.$1.45-1.36%

CMPXCompass Therapeutics, Inc.

CMPXCompass Therapeutics, Inc.$2.07+7.25%

EOLSEvolus, Inc.

EOLSEvolus, Inc.$6.09-5.58%

MNPRMonopar Therapeutics Inc.

MNPRMonopar Therapeutics Inc.$63.12+0.70%

VREXVarex Imaging Corporation

VREXVarex Imaging Corporation$10.07-0.59%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

Questions About ORGO

What is the current price of Organogenesis?

Organogenesis is trading at $2.67 per share.

What is the 52-week range for Organogenesis?

Over the past 52 weeks, Organogenesis has traded between $2.04 and $7.08.

How much debt does Organogenesis have?

As of the most recent reporting period, Organogenesis reported total debt of $70.86M.

How much cash does Organogenesis have on hand?

Organogenesis reported $92.10M in cash and cash equivalents in its most recent financial results.

What is Organogenesis’s dividend yield?

Organogenesis does not currently have a dividend yield.

Organogenesis

Organogenesis Financials at a Glance

ORGO News

ORGO Sales Drop 23%

Why Organogenesis Holding Stock Plummeted by 18% Today

Why Shares of Organogenesis Holdings Are Up Thursday

Why Shares of Organogenesis Holdings Are Dropping Thursday

Why Shares of Organogenesis Climbed Wednesday

Why Shares of Organogenesis Holdings Jumped Thursday

Why Organogenesis Stock Is Tumbling Today

Is This Healthcare Stock a Value Trap?

ORGO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Organogenesis

ORGO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Organogenesis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ORGO

What is the current price of Organogenesis?

What is the 52-week range for Organogenesis?

How much debt does Organogenesis have?

How much cash does Organogenesis have on hand?

What is Organogenesis’s dividend yield?

Premium Investing Services